CME Group Inc. (CME) Stock Analysis
Financial Services · Financial Data & Stock Exchanges
Sell if holding. Analyst target reached at $287.32 — A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: CME Globex electronic platform (93.0%).
CME Group operates CME, CBOT, NYMEX, and COMEX futures and options exchanges plus BrokerTec and EBS for fixed income and FX trading, offering derivatives across interest rates, equity indices, FX, agricultural commodities, energy, metals, and cryptocurrencies. Revenue is... Read more
Sell if holding. Analyst target reached at $287.32 — A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: CME Globex electronic platform (93.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.5/10, moderate confidence.
Passes 4/6 gates (clean insider activity, no SEC red flags, earnings proximity 82d clear, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: moderate.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHProductCME Globex electronic platform93%10-K Item 1A: 'In 2025, 93% of our overall contract volume was generated through electronic trading on our CME Globex electronic platform.'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
1 floor-breaker
Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $287.32 — A.R:R is negative (-0.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Product: CME Globex electronic platform (93.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $275.14. Score 5.5/10, moderate confidence.
Take-profit target: $306.43 (+6.7% upside). Prior stop was $275.14. Stop-loss: $275.14.
Concentration risk — Product: CME Globex electronic platform (93.0%); Analyst target reached - limited upside remaining; Expensive valuation.
CME Group Inc. trades at a P/E of 24.5 (forward 22.3). TrendMatrix value score: 3.2/10. Verdict: Sell.
20 analysts cover CME with a consensus score of 3.5/5. Average price target: $307.
What does CME Group Inc. do?CME Group operates CME, CBOT, NYMEX, and COMEX futures and options exchanges plus BrokerTec and EBS for fixed income...
CME Group operates CME, CBOT, NYMEX, and COMEX futures and options exchanges plus BrokerTec and EBS for fixed income and FX trading, offering derivatives across interest rates, equity indices, FX, agricultural commodities, energy, metals, and cryptocurrencies. Revenue is substantially derived from transaction fees; 93% of 2025 contract volume was generated electronically via CME Globex.